Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.
about
Virus-host coevolution: common patterns of nucleotide motif usage in Flaviviridae and their hostsCommon molecular mechanism of the hepatic lesion and the cardiac parasympathetic regulation in chronic hepatitis C infection: a critical role for the muscarinic receptor type 3.Autoimmune thrombocytopenia in response to splenectomy in cirrhotic patients with accompanying hepatitis C.Autoimmunity and environment: am I at risk?Prevalence of autoantibodies and the risk of autoimmune thyroid disease in children with chronic hepatitis C virus infection treated with interferon-alphaLiver immunology.Impact of parietal cell autoantibodies and non-organ-specific autoantibodies on the treatment outcome of patients with hepatitis C virus infection: a pilot studyClinical associations and potential novel antigenic targets of autoantibodies directed against rods and rings in chronic hepatitis C infection.Helicobacter pylori and autoimmune disease: cause or bystander.The immunopathogenetic role of autoantibodies in canine autoimmune hepatitis: lessons to learn from human autoimmune hepatitis.Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies.Immunopathogenesis of primary biliary cirrhosis: an old wives' tale.Extrahepatic manifestations and autoantibodies in patients with hepatitis C virus infection.Role for mycobacterial infection in pathogenesis of primary biliary cirrhosis?Tuberculosis is not a risk factor for primary biliary cirrhosis: a review of the literature.The Presence of Autoantibodies to Cytoplasmic Rod and Ring Particles in the Serum of Patients with Chronic Hepatitis C Virus Infection.Cutting edge issues in autoimmune hepatitis.Diagnosis, pathogenesis, and treatment of autoimmune hepatitis after liver transplantation.Review article: overlap syndromes and autoimmune liver disease.Autoimmune manifestations in viral hepatitis.Hepatitis C virus and autoimmunity.Autoantibodies in liver disease: important clues for the diagnosis, disease activity and prognosis.Contemporary issues and future directions in autoimmune hepatitis.De novo autoimmune hepatitis after liver transplantation: A focus on glutathione S-transferase theta 1.Lupus-like Immune Complex-mediated Glomerulonephritis in Patients with Hepatitis C Virus Infection Treated with Oral, Interferon-free, Direct-acting Antiviral Therapy.Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models.Suspected and unsuspected factors in the multifaceted immunopathology of viral hepatitis.Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity.Non-organ-specific autoantibodies in Indian patients with chronic liver disease.Monoclonal auto-antibodies and sera of autoimmune patients react with Plasmodium falciparum and inhibit its in vitro growth.Clinical significance of organ- and non-organ-specific autoantibodies on the response to anti-viral treatment of patients with chronic hepatitis C.Autoimmune hepatitis in a 20-year-old African American man.Autoantibodies in chronic hepatitis C virus infection: impact on clinical outcomes and extrahepatic manifestations.
P2860
Q24498559-52C8FD88-7A20-4B28-AB9D-0965E83198DCQ30385922-81F89EA4-0B21-4F72-B9E3-B662FA96F837Q33370546-21E19F24-4073-455B-99F7-8E7585C3872DQ33825348-5615E7A1-BD42-4889-BC2C-645403895388Q33909777-6677AF38-FFE1-4AA1-963D-5A5AA224CB1EQ34359990-D3F56BF3-50AB-4B4E-ABF8-75F73D0E38F9Q34605699-90C96886-A45F-42F3-8521-8A54C3757C51Q34626547-3C399FD7-AAF4-4D7F-8177-82B8BC0652D1Q35103687-3B3BFA45-FEC2-4666-A183-F81399C7800DQ35309836-40BC9496-581D-4DE4-AC4E-6270745D4820Q35309854-36B9757C-D1C9-40BC-B763-F1C9A77B7C89Q35614763-B35B8729-8AEA-45E9-8302-717D589D6A97Q36231193-3A501DF2-E963-420D-B5A0-8C2FD365842FQ36248162-0E1C49BD-28B9-4E19-A530-588FA188F1A3Q36417949-8A9F1BDF-D75A-4274-9420-5C1F9A9D3724Q37587194-AD9BF73C-329E-4BFF-B419-F09B7B48B250Q37826110-7475B6CF-561C-4C79-9FE2-20C4F32AD82EQ38007886-173EB28E-7A49-4286-ACA9-6144C3F174CEQ38027909-500D1201-7726-4160-B1C0-CFAC67948E0DQ38046450-49DCF648-4B12-4213-83D4-E774D7129876Q38497354-3864E420-F9AD-435B-8CE2-F92B4F6C8C86Q38497449-7275861A-0A5D-44DE-9C04-0A93CFFE758FQ38842072-C59CD981-1068-486A-AC42-8F53436B1E9FQ38973707-8DCEC224-AAB1-49B3-8909-EAE548873A71Q40404776-65B0CF0C-960A-4E3A-BD8F-0CABE246534AQ42235285-8B990832-4433-4077-99E8-1EE85D5CD819Q42987385-E80DC2F4-CC5D-4BF0-A7E2-70F38947B2C6Q45129507-FCE693A9-2DC8-47F5-9191-6FBC3902F562Q47196169-AE4A94AD-5660-4DA4-9035-5EC048EF1393Q47989219-C2F62F62-B5E3-4859-BFAD-89B8EDBDEDBBQ50574844-349407D3-A993-47A9-BE5B-7152BAFC4AC9Q53842245-1CA90FA5-5800-4768-A338-CFD8BC956217Q55027429-136DC716-177D-4A7D-8EF4-E99EB1F5BAD9
P2860
Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Mimicry between the hepatitis ...... c hepatitis C virus infection.
@en
Mimicry between the hepatitis ...... c hepatitis C virus infection.
@nl
type
label
Mimicry between the hepatitis ...... c hepatitis C virus infection.
@en
Mimicry between the hepatitis ...... c hepatitis C virus infection.
@nl
prefLabel
Mimicry between the hepatitis ...... c hepatitis C virus infection.
@en
Mimicry between the hepatitis ...... c hepatitis C virus infection.
@nl
P2093
P2860
P50
P1476
Mimicry between the hepatitis ...... ic hepatitis C virus infection
@en
P2093
A Vegnente
G Mieli-Vergani
G V Gregorio
P2860
P304
P356
10.1046/J.1365-2249.2003.02229.X
P577
2003-09-01T00:00:00Z